[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$novo](/topic/$novo)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$novo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$novo/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-10-19  

**Most Supportive Themes**
- **FDA Approval for MASH:** (40%) Novo Nordisk's Wegovy receives FDA approval for liver disease, boosting investor confidence.
- **Positive Outlook:** (35%) Analysts and investors remain optimistic about Novo Nordisk's future.
  
**Most Critical Themes**
- **Manufacturing Concerns:** (10%)  Concerns about potential manufacturing issues for Novo Nordisk's injectable medications.
- **Competition from Eli Lilly:** (15%)  Mentions of Eli Lilly's competition in the weight loss and diabetes market.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XXX      | X% | XXXXX   | XX% | XXX      | X% |
|         |          |    |         |     |          |    |
| Total   | XXX      | X% | XXXXX   | XX% | XXX      | X% |